FDA grants Breakthrough Therapy Designation to tezepelumab for severe asthma https://t.co/B4xJ2o7VGt
— Marisa Peer (@PeerMarisa) September 25, 2018
from Twitter https://twitter.com/PeerMarisa
September 25, 2018 at 02:12AM
Tuesday, September 25, 2018
FDA grants Breakthrough Therapy Designation to tezepelumab for severe asthma https://t.co/B4xJ2o7VGt
from Twitter https://twitter.com/PeerMarisa
September 25, 2018 at 02:12AM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment